These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29614698)

  • 1. Cognitive Rehabilitation in Parkinson's Disease: A Systematic Review.
    Alzahrani H; Venneri A
    J Parkinsons Dis; 2018; 8(2):233-245. PubMed ID: 29614698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Everyday functioning of people with Parkinson's disease and impairments in executive function: a qualitative investigation.
    Kudlicka A; Hindle JV; Spencer LE; Clare L
    Disabil Rehabil; 2018 Oct; 40(20):2351-2363. PubMed ID: 28597694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's patients' executive profile and goals they set for improvement: Why is cognitive rehabilitation not common practice?
    Vlagsma TT; Koerts J; Fasotti L; Tucha O; van Laar T; Dijkstra H; Spikman JM
    Neuropsychol Rehabil; 2016; 26(2):216-35. PubMed ID: 25693688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Computer-Based Cognitive Rehabilitation on Working Memory in Patients with Parkinson's Disease: A Systematic Review.
    Svaerke K; Niemeijer M; Løkkegaard A
    J Parkinsons Dis; 2020; 10(1):47-57. PubMed ID: 31609698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cognitive rehabilitation in Parkinson disease: a meta-analysis.
    Giustiniani A; Maistrello L; Danesin L; Rigon E; Burgio F
    Neurol Sci; 2022 Apr; 43(4):2323-2337. PubMed ID: 35098360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective memory functioning in individuals with Parkinson's disease: a systematic review.
    Costa A; Caltagirone C; Carlesimo GA
    Clin Neuropsychol; 2018 Jul; 32(5):937-959. PubMed ID: 29183225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson's disease: A systematic review.
    Alzahrani H; Venneri A
    J Neurol Sci; 2015 Sep; 356(1-2):32-44. PubMed ID: 26123201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of ReSET; a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease.
    Vlagsma TT; Duits AA; Dijkstra HT; van Laar T; Spikman JM
    Neuropsychol Rehabil; 2020 Jan; 30(1):67-84. PubMed ID: 29566588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurorehabilitation in Parkinson's Disease: A Critical Review of Cognitive Rehabilitation Effects on Cognition and Brain.
    Díez-Cirarda M; Ibarretxe-Bilbao N; Peña J; Ojeda N
    Neural Plast; 2018; 2018():2651918. PubMed ID: 29853840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible?
    Biundo R; Weis L; Fiorenzato E; Antonini A
    Arch Clin Neuropsychol; 2017 Nov; 32(7):840-860. PubMed ID: 28961738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive rehabilitation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial.
    Hindle JV; Watermeyer TJ; Roberts J; Martyr A; Lloyd-Williams H; Brand A; Gutting P; Hoare Z; Edwards RT; Clare L
    Trials; 2016 Mar; 17():152. PubMed ID: 27000036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Parkin'Play study: protocol of a phase II randomized controlled trial to assess the effects of a health game on cognition in Parkinson's disease.
    van de Weijer SC; Duits AA; Bloem BR; Kessels RP; Jansen JF; Köhler S; Tissingh G; Kuijf ML
    BMC Neurol; 2016 Nov; 16(1):209. PubMed ID: 27809791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to Cognitive Impairment in Parkinson's Disease.
    Zhang Q; Aldridge GM; Narayanan NS; Anderson SW; Uc EY
    Neurotherapeutics; 2020 Oct; 17(4):1495-1510. PubMed ID: 33205381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive rehabilitation in multiple sclerosis: A systematic review.
    Mitolo M; Venneri A; Wilkinson ID; Sharrack B
    J Neurol Sci; 2015 Jul; 354(1-2):1-9. PubMed ID: 25998261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerobic exercise is more effective than goal-based exercise for the treatment of cognition in Parkinson's disease.
    Silveira CRA; Roy EA; Intzandt BN; Almeida QJ
    Brain Cogn; 2018 Apr; 122():1-8. PubMed ID: 29331916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology-based cognitive training and rehabilitation interventions for individuals with mild cognitive impairment: a systematic review.
    Ge S; Zhu Z; Wu B; McConnell ES
    BMC Geriatr; 2018 Sep; 18(1):213. PubMed ID: 30219036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
    Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of virtual reality on outcomes in rehabilitation of Parkinson's disease: meta-analysis and systematic review in 1031 participants.
    Triegaardt J; Han TS; Sada C; Sharma S; Sharma P
    Neurol Sci; 2020 Mar; 41(3):529-536. PubMed ID: 31808000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.